FIDscreen is the first point-of-care testing device detecting functional iron deficiency, developed by FerroSens GmbH. The patented and innovative device will revolutionize the diagnostic approach to iron deficiency in different indications, as it combines the following characteristics:
EARLY & RELIABLE DETECTION
NON-INVASIVE & SIMPLE MEASUREMENT
FIDscreen measures Zinc protoporphyrin, an established marker for iron deficiency that is insensitive to acute infections and detects iron deficiency at an earlier stage than hemoglobin. This offers direct access to diagnosis and treatment for functional iron deficiency.
FIDscreen uses an innovative optical method to detect iron deficiency in the lower lip. This avoids a stressful procedure of finger- or venipuncture.
FIDscreen requires no laboratory processing. The device provides a reliable result in about one minute. This allows the physician to start the treatment immediately.
An investment in FIDscreen gives physicians the opportunity to offer iron deficiency screening for their patients. Due to the importance of this diagnostic method, the investment has the chance to amortize in a short time period.
The idea for a non-invasive point of care testing device measuring iron deficiency originates from the World Health Organization (WHO) in 2011. In childhood, iron deficiency may affect the cognitive development, which can result in permanent deficits. Additionally, iron deficiency increases the susceptibility to infection, for example in malaria endemic areas. Iron deficiency is relatively easy to treat, but the iron supplementation for individuals, who do not suffer from iron deficiency, does more harm than good. As a consequence, the WHO stopped its area-wide and untargeted programs for iron supplementation and declared the development of a device that non-invasively detects iron deficiency under field conditions a research priority.
PROOF OF PRINCIPLE
PROOF OF CONCEPT
EXIST - FUNDING
The WHO proclaimed “non-invasive detection of iron deficiency” as research priority and the founders started the research project.
The founders established a method that allows a fast and reliable iron deficiency detection on whole blood.
The founders developed a series of laboratory prototypes leading to a device that was successfully evaluated in a clinical study on women after childbirth.
FerroSens received governmental funding from the German Federal Ministry for Economic Affairs and Energy to develop a market-ready device and found a spin-off Company.
The founders published the results of the first clinical study in Nature Communications, which generated wide-spread attention to our method and team.
FerroSens finished a second clinical study on children.
WHO WE ARE
Dr. Christian Homann
Dr. Georg Hennig
- Christian Homann is the CEO of FerroSens GmbH and is responsible for Research and Development as Managing Partner (“Gesellschafter-Geschäftsführer”).
- He has 12 years experience in the development of optical laser methods and is an expert in clinical studies. He is in control of the medical device approval and clinical studies.
- Christian holds a PhD (summa cum laude) from LMU Munich.
- Georg Hennig is responsible as the Chief Technology Officer.
- He has been in charge of the development and enhancement of FIDscreen since 2011. Due to his deep understanding of both the technological and medical requirements, he plays a key role in the development of FIDscreen.
- Georg holds a PhD (summa cum laude) from the Medical Faculty of the LMU Munich.
- Nicolas Hoehne joined the project team in Q2/2015 and is in charge as the Chief Financial Officer and Managing Partner (“Gesellschafter-Geschäftsführer”).
- He is responsible for Finance, Controlling and Project Management.
- Nicolas is a Chartered Global Management Accountant and holds a MSc in Controlling from the UCD Michael Smurfit Graduate School Dublin.
- Alexander Lang is in charge of quality management, production and logistics.
- Alexander has more than 2 years experience in medical device development. He has been trained extensively in quality management issues and is establishing a large part of the quality management system.
- He holds a MSc in Physics of condensed matter from TU Munich.
FerroSens is currently funded by the EXIST Forschungstransfer of the German Federal Ministry for Economic Affairs and Energy.
IF YOU ARE INTERESTED IN MORE
IN THE NEWS
FerroSens won two national business plan competitions with focus on life sciences.
FerroSens is rated as within the top 50 start-ups in Germany.